LRND

New York Life Investments ETF Trust NYLI U.S. Large Cap R&D Leaders ETF

$40.32
+0.00%
Market closed. Last update: 10:57 PM ET

📎 Investment Objective

The NYLI U.S. Large Cap R&D Leaders ETF seeks to provide investment results that closely correspond, before fees and expenses, to the performance of the NYLI U.S. Large Cap R&D Leaders Index.

Overview

ETF tracking New York Life Investments ETF Trust NYLI U.S. Large Cap R&D Leaders ETF

Category Large Cap
Issuer Other
Inception Date 2022-10-18
Market Cap $8.1M
Average Volume N/A
Dividend Yield 0.83%
52-Week Range $28.24 - $41.65
VWAP $40.32

Performance

Loading performance data...

Price Chart

Investment Summary

📎 Investment Objective

The NYLI U.S. Large Cap R&D Leaders ETF seeks to provide investment results that closely correspond, before fees and expenses, to the performance of the NYLI U.S. Large Cap R&D Leaders Index.

🎯 Investment Strategy

The ETF invests primarily in a portfolio of large-capitalization U.S. stocks that are leaders in research and development (R&D) spending. The fund's portfolio is designed to track the NYLI U.S. Large Cap R&D Leaders Index, which selects and weights companies based on their R&D investment as a percentage of revenue.

✨ Key Features

  • Focuses on large-cap U.S. companies with high R&D investment
  • Seeks to provide exposure to innovative, technology-driven businesses
  • Passively managed to track the NYLI U.S. Large Cap R&D Leaders Index
  • Low expense ratio of 0.00%

⚠️ Primary Risks

  • Market risk: The value of the fund's holdings may decline due to general market and economic conditions.
  • Sector concentration risk: The fund's performance may be more volatile due to its focus on the technology and innovation sectors.
  • Tracking error risk: The fund may not perfectly track the performance of its underlying index.
  • Limited performance history: As a new fund, it has a limited track record to evaluate its long-term performance.

👤 Best For

This ETF may be suitable for investors seeking exposure to large-cap U.S. companies with a focus on research and development, as part of a diversified portfolio. Investors should have a long-term investment horizon and be willing to accept the volatility associated with investing in innovative, technology-driven businesses.